Homology Medicines (BATS:FIXX) Insider Shelia Violette Sells 2,798 Shares of Stock

Homology Medicines, Inc. (BATS:FIXX) insider Shelia Violette sold 2,798 shares of Homology Medicines stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $16.56, for a total transaction of $46,334.88. Following the transaction, the insider directly owned 127,771 shares of the company’s stock, valued at approximately $2,115,887.76. This trade represents a 2.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Price Performance

FIXX opened at $12.73 on Friday. Homology Medicines, Inc. has a fifty-two week low of $12.02 and a fifty-two week high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.